Gravitas Medical, Inc. Announces SECOND FDA Clearance for its Entarik System; Neonatal Patients to Benefit from Enteral Nutrition Innovation
Gravitas Medical received NEONATAL FDA 510(k) clearance for the Entarik system, which aids in the placement of feeding tubes and continuously monitors feeding tube position, gastric and esophageal temperature, and gastrointestinal impedance and reflux.
BERKELEY, Calif., Nov. 27, 2024 /PRNewswire-PRWeb/ — Gravitas Medical, Inc. is pleased to announce that it received Neonatal 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance allows Gravitas Medical to market its revolutionary Entarik technology to the US neonatal population.
